查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1809746

全球血液製品市场（按产品、成分、加工自动化、製备方法、应用和最终用户）预测（2025-2030 年）

Blood Preparation Market by Offerings, Component, Processing Automation, Preparation Method, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球血液製品市场规模预计2024年将达到455.4亿美元，2025年将达480.9亿美元，2030年将达到636.6亿美元，复合年增长率为5.74%。

主要市场统计数据
基准年：2024年 455.4亿美元
预计年份：2025年 480.9亿美元
预测年份：2030年 636.6亿美元
复合年增长率（%） 5.74%

全面了解当前血液製品生态系统，重点关注影响营运策略的技术推动因素、相关人员的优先事项和采购考虑因素

随着医疗机构寻求更安全、更有效率、更可追溯的生物製药流程，血液製品生态系统正经历技术和营运的快速改进。血液采集和储存硬体的进步，加上用于机构管理和温度监控的软体层的不断扩展，正在重新定义捐血、处理、储存和分配的工作流程。从血库和医院输血服务到门诊手术中心和研究机构，相关人员正在重新调整采购重点，以强调弹性、自动化和整合品管。

对技术、营运和采购转型变化的综合看法，这些变化正在重新定义血液製品的安全性、自动化和供应商参与度

血液製品产业格局正沿着几个相互融合的趋势发生变化，这些趋势正在改变供应链和临床实践。首先，自动化正在超越单一仪器的优势，转向整合自动化成分提取、离心和温度感知储存系统的协同工作流程，从而减少人工劳动和差异性。其次，白血球减少、辐照和病原体惰性等安全技术正在更早纳入加工流程中，以降低下游风险并支援更广泛的临床使用案例。第三，软体驱动的流程管治日趋成熟，温度监控和血液机构系统提供了先前依赖人工记录的审核和合规性支援。

清楚分析累积关税如何重塑整个血液製品价值链的采购动态、供应商策略和营运弹性

近期的关税措施为整个血液製品价值链的采购和供应弹性带来了复杂性。进口零件、资本设备和某些耗材的累积关税增加了依赖跨境供应商的医疗保健机构的总体拥有成本，促使许多机构重新评估供应商集中度和前置作业时间。因此，采购团队正在优先考虑双源策略，并加强与区域製造商的合作，以减轻贸易政策波动的影响。

关键细分洞察，将产品、加工方法、临床用途、自动化程度、成分和最终用户需求与采购和创新重点进行映射

细分推动产品开发蓝图和采购选择，因为最终用户需要清楚了解产品如何满足他们的临床和营运需求。这个市场由耗材、设备和软体组成。耗材包括血液分离套件、血袋系统、白血球减少过滤器、转移装置、管路和针头等，这些决定了血液中心和医院每次手术的成本和利润。设备包括采集设备、辐照设备、病原体减少系统、处理设备和储存设施。采集设备进一步分为血液分离机和采血搅拌机。处理设备包括自动成分提取机和离心机。储存设施包括血库冰箱、超低温冷冻库、血浆冷冻库、血小板培养箱和搅拌器。软体涵盖血液营业单位解决方案和温度监控平台，可实现库存管理和监管可追溯性。

细緻入微的区域综合分析，阐明美洲、欧洲、中东和非洲地区以及亚太地区的动态将如何影响采用、供应弹性和监管合规性

区域动态对供应链、监管预期以及新血液製品技术的采用时间表有重大影响。美洲地区拥有庞大且完善的血液服务基础设施、先进的医院系统，日益重视自动化和安全技术。在这种环境下，采购决策受到报销框架、既定的供应商关係以及温度敏感产品远距配送的现实影响。

提供可操作的企业级洞察，了解供应商策略、服务模式和伙伴关係方式如何塑造整个血液製品生态系统的竞争优势

血液製品领域的竞争力更取决于生态系定位，而非单一产品优势。领先的供应商透过整合抛弃式、固定设备和软体功能的综合产品组合实现差异化，从而实现端到端的价值提案，满足采购偏好，减少供应商接口，并实现可预测的生命週期成本。领先供应商采取的策略行动包括：与临床网路建立伙伴关係检验新的加工技术；投资区域服务点以缩短维护前置作业时间；以及提供培训和认证计划以减少采用先进设备的阻力。

为供应商、卫生系统和采购领导者提供实用且优先的建议，以增强血液製品的弹性、安全性和技术整合

产业领导者应优先考虑一系列策略行动，直接解决供应弹性、安全性和整合问题。首先，采用模组化采购策略，平衡血液采集和储存设备的资本投资与耗材及维护的长期合同，以稳定总体拥有成本，并降低受关税主导的价格筹资策略风险。其次，加快血液机构和温度监测的软体集成，以创建透明、审核的工作流程，减少人为错误并支援法规遵循。

一个强大的多方法研究框架，结合一级相关人员访谈、二级技术和监管整合以及三角主题检验，以支持策略洞察

本执行摘要的分析结合了多种方法的研究途径，旨在产生可操作的、基于证据的见解。二次资讯整合利用了同行评审文献、监管指南、技术标准和製造商技术规范，以全面整体情况技术、流程和合规性要求。初步研究透过与血库主任、医院输血科主任、采购专业人员、临床病理学家和设备工程师进行结构化访谈，以突显现实世界中采用此技术的限制和驱动因素。

策略重点与营运协调的关键整合，将安全性、弹性和完整性统一为血液製品相关人员的核心必要事项

这意味着医疗保健机构和供应商必须从交易互动转向整合价值的伙伴关係关係，将弹性采购、自动化和数据驱动的品质系统结合在一起。医疗保健机构不应将流程自动化、病原体控制和软体管治的投资仅视为资本计划，而应将其视为实现临床一致性和供应弹性的策略性槓桿。提供模组化、服务丰富且可互通解决方案的供应商最有能力满足从门诊手术中心到大型医院网路等不同终端使用者的细微需求。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章市场动态

  • 照护现场血液製品设备的出现，方便了偏远诊所的现场输血准备
  • 利用冷冻干燥技术将常温血液製品转变为无低温运输储存解决方案
  • 自动血液分离系统的整合可加速成分分离并降低污染风险
  • 增加对单一捐赠者血液分离平台的投资，以优化产量并最大限度地降低捐赠者暴露风险
  • 引入人工智慧捐赠者筛检演算法，提高匹配准确性并减少输血反应
  • 开发一种通用血型酶，可转换 A 和 B 抗原，以缓解相容性问题
  • 加速采用血小板和血浆的病原体减少技术，以标准化安全性并延长保质期
  • 先进的红血球添加剂和復原解决方案可提高输血后的活力并延长保质期
  • 使用 RFID 和物联网资料记录器实现端到端数位可追溯性，以确保监管炼和温度合规性
  • 由于捐赠者的不确定性和区域性血液短缺迫使医院寻求稳定的供应，合约血液处理和物流外包正在增加

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章 2025年美国关税的累积影响

第八章血液製品市场类型

  • 耗材
    • 血液成分采集试剂套件
    • 血袋系统
    • 白血球去除过滤器
    • 转移装置
    • 管子和针头
  • 装置
    • 收集装置
      • 血液采集机
      • 采血搅拌机
    • 照射装置
    • 病原体减少系统
    • 加工设备
      • 自动元件撷取装置
      • 离心机
    • 仓储设备
      • 血库冰箱
      • 低温冷冻库
      • 血浆冷冻库
      • 血小板培养箱和搅拌器
  • 软体
    • 血液营业单位
    • 温度监测

第九章血液製品市场（依成分）

  • 电浆
  • 血小板
  • 红血球
  • 全血

第十章血液製品市场（按加工自动化）

  • 全自动
  • 手动的
  • 半自动

第11章血液製品市场依製备方法

  • 单采血液成分处理
  • 提取工作流程
  • 冷冻储存
  • 辐照
  • 白血球减少症
  • 病原体灭活
  • 清洗和调整音量
  • 全血处理

第十二章血液製品市场应用

  • 血浆衍生疗法
    • 自体免疫和神经系统疾病
    • 肝病及严重疾病治疗
    • 原发性免疫力缺乏缺陷症
  • 研究与生物製造
  • 输血支持
    • 贫血管理
    • 心血管和移植
    • 血液疾病
    • 妇产科
    • 肿瘤治疗

第十三章 血液製品市场（依最终用户）

  • 门诊手术中心
  • 血库
  • 诊所
  • 医院

第 14 章：美洲血液製品市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

15. 欧洲、中东和非洲血液製品市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

第16章：亚太血液製品市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第十七章竞争格局

  • 市占率分析（2024年）
  • FPNV定位矩阵（2024年）
  • 竞争分析
    • Fresenius Kabi AG
    • Terumo Corporation
    • Grifols, SA
    • GVS SpA
    • Macopharma SAS
    • Baxter International Inc.
    • CSL Limited
    • B. Braun Melsungen AG
    • Ortho Clinical Diagnostics Inc.
    • Abbott Laboratories
    • AdvaCare Pharma
    • AstraZeneca PLC
    • Bayer AG
    • Becton, Dickinson, and Company
    • Cardinal Health
    • Daiichi Sankyo
    • Exelint International, Co.
    • GlaxoSmithKline PLC
    • Greiner Bio-One International GmbH
    • Medtronic PLC
    • Pfizer Inc.
    • QIAGEN NV
    • SARSTEDT AG & Co. KG
    • Shanghai Kohope Medical Devices Co., Ltd.
    • Immucor, Inc.
    • Octapharma AG
    • Kedrion Holding SpA
    • LFB SA
    • Sanquin
    • Medline Industries, Inc.
    • Mitra Industries Private Limited
    • Delcon SRL
    • Labtron Equipment Ltd
    • Nipro Corporation
    • Labotronics Scientific LTD.

第十八章 研究人工智慧

第十九章 研究统计

第二十章 研究联络人

第21章 研究报导

第22章 附录

Product Code: MRR-535C62918769

The Blood Preparation Market was valued at USD 45.54 billion in 2024 and is projected to grow to USD 48.09 billion in 2025, with a CAGR of 5.74%, reaching USD 63.66 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 45.54 billion
Estimated Year [2025] USD 48.09 billion
Forecast Year [2030] USD 63.66 billion
CAGR (%) 5.74%

A comprehensive orientation to the current blood preparation ecosystem highlighting technological enablers, stakeholder priorities, and procurement considerations shaping operational strategy

The blood preparation ecosystem is undergoing a period of rapid technological and operational refinement as institutions seek safer, more efficient, and more traceable flows of biological products. Advances in collection and storage hardware, combined with a growing software layer for establishment management and temperature monitoring, are redefining workflows across donation, processing, storage, and distribution. Stakeholders from blood banks and hospital transfusion services to ambulatory surgical centers and research organizations are recalibrating procurement priorities to emphasize resiliency, automation, and integrated quality controls.

Against this backdrop, procurement decision-makers must balance capital investments in collection devices, pathogen reduction systems, and storage infrastructure with recurring consumable needs such as apheresis kits, tubing, and filters. At the same time, clinical teams are emphasizing component integrity for plasma-derived therapies, transfusion support in oncology and cardiology, and specialized needs for immune and hepatic care. The introductory framing here establishes the operational tensions that follow through the analysis: securing supply continuity, minimizing contamination risk, and enabling seamless traceability through both hardware and software interventions.

An integrated view of transformative technological, operational, and procurement shifts that are redefining safety, automation, and supplier engagement across blood preparation

The landscape of blood preparation is shifting along several convergent vectors that are transforming both supply chains and clinical practice. First, automation is moving beyond single-instrument gains toward orchestrated workflows that integrate automated component extraction, centrifugation, and temperature-aware storage systems, thereby reducing manual handling and variability. Second, safety technologies such as leukoreduction, irradiation, and pathogen inactivation are becoming embedded earlier in processing pathways to reduce downstream risk and support broader clinical use cases. Third, software-enabled process governance is maturing, with temperature monitoring and blood establishment systems providing auditability and compliance support that used to rely on manual recordkeeping.

These shifts are complemented by evolving end-user expectations; hospitals and clinics are increasingly demanding modular systems that can scale with changing case mixes and regulatory requirements. Research and biomanufacturing applications are driving adaptations in processing and storage capabilities to support plasma-derived therapies and novel biologic workflows. Finally, the interplay between disposables and capital equipment is changing procurement models, encouraging suppliers to present lifecycle propositions rather than standalone product sales. Together, these transformative shifts necessitate that clinical, operational, and purchasing leaders rethink supplier relationships, maintenance models, and integration strategies to capture the full value of technological advances.

A clear analysis of how cumulative tariff measures have reshaped procurement dynamics, supplier strategies, and operational resilience across the blood preparation value chain

Recent tariff actions have introduced a material layer of complexity into procurement and supply resilience across the blood preparation value chain. Cumulative tariff measures on imported components, capital equipment, and certain consumables have increased the total cost of ownership for institutions reliant on cross-border suppliers, prompting many organizations to reassess supplier concentration and lead times. As a result, procurement teams are prioritizing dual-sourcing strategies and closer collaboration with regional manufacturers to mitigate exposure to trade policy volatility.

Operationally, tariffs have affected decisions around capital replacement cycles and servicing contracts for items such as apheresis machines, pathogen reduction systems, and temperature-sensitive storage equipment. Institutions that had planned synchronized upgrades are reconsidering schedules to avoid short-term price escalations while continuing to manage compliance and safety imperatives. On the supplier side, manufacturers are responding with localized manufacturing investments, regional distribution hubs, and revised commercial models that emphasize bundled service agreements to offset tariff-driven margins. In parallel, regulatory and customs processing requirements associated with tariff regimes are demanding greater documentation and logistics lead time, which influences blood bank inventory strategies and the timing of elective procedures that depend on reliable transfusion support.

Essential segmentation insights that map offerings, processing methods, clinical applications, automation levels, components, and end-user demands to procurement and innovation priorities

Segmentation drives both product development roadmaps and procurement choices because end users require clarity on how offerings map to clinical and operational needs. Based on offerings, the market encompasses Disposables & Consumables, Equipment, and Software. Disposables & Consumables include items such as apheresis kits, blood bag systems, leukocyte reduction filters, transfer sets, and tubing and needles that determine per-procedure cost and margin for blood centers and hospitals. Equipment comprises collection devices, irradiators, pathogen reduction systems, processing equipment, and storage equipment; collection devices further break down into apheresis machines and blood collection mixers, processing equipment includes automated component extractors and centrifuges, and storage equipment captures blood bank refrigerators, cryogenic freezers, plasma freezers, and platelet incubators and agitators. Software covers blood establishment solutions and temperature monitoring platforms that enable inventory control and regulatory traceability.

Based on component, segmentation differentiates plasma, platelets, red blood cells, and whole blood, each with distinct processing, storage, and clinical utilization profiles. Based on processing automation, offerings span fully automated systems, manual workflows, and semi-automated solutions, which influence staffing models and throughput. Based on preparation method, the range includes apheresis processing, extraction workflows, freezing and cryopreservation, irradiation, leukoreduction, pathogen inactivation, washing and volume adjustment, and whole blood processing, each requiring specific consumables and equipment footprints. Based on application, the market addresses plasma-derived therapies, research and biomanufacturing, and transfusion support; plasma-derived therapies further subdivide into autoimmune and neurologic disorders, liver disease and critical care, and primary immunodeficiency, while transfusion support addresses anemia management, cardiovascular and transplant care, hematological disorders, obstetrics and gynecology, and oncology treatments. Finally, based on end user, demand channels include ambulatory surgical centers, blood banks, clinics, and hospitals, with each end user imposing different scale and compliance requirements that affect product selection and service needs.

A nuanced regional intelligence synthesis describing how Americas, Europe Middle East Africa, and Asia-Pacific dynamics influence adoption, supply resilience, and regulatory compliance

Regional dynamics exert substantial influence on supply chains, regulatory expectations, and adoption timelines for new blood preparation technologies. The Americas context features a mix of large established blood service infrastructures, advanced hospital systems, and an increasing focus on automation and safety technologies. In this environment, procurement decisions are influenced by reimbursement frameworks, established supplier relationships, and the logistical realities of long-distance distribution for temperature-sensitive products.

Europe, the Middle East & Africa presents a heterogeneous tableau where high-regulation markets drive early adoption of compliance-oriented software and pathogen reduction technologies, while emerging markets in the region prioritize scalable, cost-effective disposables and resilient storage solutions. Adoption patterns in this region are mediated by national blood service models and regional trade dynamics. The Asia-Pacific region is characterized by rapid capacity expansion in both hospital services and plasma collection infrastructure, a growing appetite for localized manufacturing to reduce import dependency, and increasing investment in automation and digital quality systems. Across all regions, the interplay between local regulatory frameworks, tariff influences, and healthcare delivery models shapes how quickly new equipment and processes are validated and scaled.

Actionable corporate-level intelligence on how supplier strategies, service models, and partnership approaches are shaping competitive advantage across the blood preparation ecosystem

Competitive dynamics in the blood preparation space are defined less by single-product dominance and more by ecosystem positioning. Leading players differentiate through comprehensive portfolios that combine disposables, capital equipment, and software capabilities, enabling end-to-end value propositions that address procurement preference for fewer vendor interfaces and predictable lifecycle costs. Strategic behaviors observed among major suppliers include forming partnerships with clinical networks to validate new processing technologies, investing in regional service footprints to shorten maintenance lead times, and offering training and accreditation programs that lower implementation friction for sophisticated equipment.

Smaller specialized suppliers are carving sustainable niches by focusing on high-margin consumables, modular add-ons for pathogen reduction, and software modules that integrate with legacy blood establishment systems. Contract manufacturing organizations and regional device assemblers have been expanding capabilities to serve localized demand, particularly where tariff pressures incentivize domestic sourcing. Across the competitive spectrum, successful companies are aligning commercial models to emphasize bundled service agreements, data-enabled support offerings, and interoperability that eases integration with existing blood center workflows.

Practical and prioritized recommendations for suppliers, health systems, and procurement leaders to strengthen resilience, safety, and technology integration in blood preparation

Industry leaders should prioritize a portfolio of strategic actions that directly address supply resilience, safety, and integration. First, adopt a modular procurement strategy that balances capital investment in collection and storage equipment with long-term agreements for disposables and maintenance to stabilize total cost of ownership and reduce exposure to tariff-driven price shocks. Second, accelerate integration of software for blood establishment and temperature monitoring to create transparent, auditable workflows that reduce manual error and support regulatory compliance.

Third, diversify supplier relationships by qualifying regional manufacturers and contract assemblers to shorten lead times and create buffer capacity for critical consumables. Fourth, invest in phased automation that aligns with staffing realities; prioritize semi-automated interventions that deliver immediate reductions in handling risk while planning for fully automated workflows where throughput and budget permit. Fifth, create clinical-laboratory partnerships to validate pathogen reduction and leukoreduction protocols in real-world settings, generating internal evidence that supports broader adoption and payer conversations. Finally, engage proactively with policymakers and customs authorities to streamline import documentation and advocate for tariff treatment that recognizes the clinical imperative of uninterrupted blood supply.

A robust, multi-method research framework combining primary stakeholder interviews, secondary technical and regulatory synthesis, and triangulated thematic validation to underpin strategic insights

The analysis underpinning this executive summary combines a multi-method research approach designed to produce actionable, evidence-based insights. Secondary source synthesis drew on peer-reviewed literature, regulatory guidance, technical standards, and manufacturer technical specifications to build a comprehensive picture of technologies, processes, and compliance requirements. Primary research was conducted through structured interviews with blood bank directors, hospital transfusion leads, procurement professionals, clinical pathologists, and device engineers to surface real-world constraints and adoption drivers.

Data triangulation integrated qualitative interview findings with product feature mappings, supply chain case studies, and regional regulatory reviews to validate themes and identify divergence across regions and end-user types. Segmentation logic was applied iteratively to ensure that offerings, components, processing automation levels, preparation methods, applications, and end users were coherently aligned to observed purchasing behavior and clinical workflows. Where appropriate, scenario analysis was used to stress-test procurement and operational responses to tariff shifts and supply disruptions without attempting to estimate market sizes or forecast quantitative outcomes.

A decisive synthesis of strategic priorities and operational adjustments that unify safety, resilience, and integration as the central imperatives for blood preparation stakeholders

The findings converge on a clear imperative: institutions and suppliers must move from transactional interactions to integrated value partnerships that combine resilient sourcing, automation, and data-enabled quality systems. Providers should view investments in processing automation, pathogen mitigation, and software governance not merely as capital projects but as strategic enablers of clinical consistency and supply resilience. Suppliers who offer modular, service-rich, and interoperable solutions will be best positioned to meet the nuanced demands of diverse end users from ambulatory surgical centers to large hospital networks.

At the same time, procurement teams must adopt a more dynamic risk posture that accounts for tariff volatility and regional manufacturing shifts. By aligning clinical validation programs with procurement cycles and engaging in active supplier qualification, organizations can shorten time-to-adoption for high-value technologies while safeguarding continuity of supply. The conclusions here are intended to guide pragmatic decisions that improve patient safety, operational reliability, and cost transparency across the blood preparation lifecycle.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Emergence of point-of-care blood preparation devices accelerating on-site transfusion readiness in remote clinics
  • 5.2. Shift towards cold chain-free storage solutions leveraging lyophilization technology for room temperature blood products
  • 5.3. Integration of automated blood fractionation systems for faster component separation and reduced contamination risk
  • 5.4. Rising investment in single donor apheresis platforms to optimize yield and minimize donor exposure risk
  • 5.5. Implementation of AI-driven donor screening algorithms to improve match accuracy and reduce transfusion reactions
  • 5.6. Development of universal blood group enzymes to convert A and B antigens and mitigate compatibility challenges
  • 5.7. Accelerating adoption of pathogen reduction for platelets and plasma to standardize safety and extend shelf life
  • 5.8. Adoption of advanced red cell additive and rejuvenation solutions improving post-transfusion viability and enabling longer storage durations
  • 5.9. Deployment of end-to-end digital traceability with RFID and IoT dataloggers to assure chain of custody and temperature compliance
  • 5.10. Growth of contract blood processing and logistics outsourcing as hospitals seek resilient supply amid donor volatility and regional shortages

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Blood Preparation Market, by Offerings

  • 8.1. Introduction
  • 8.2. Disposables & Consumables
    • 8.2.1. Apheresis Kits
    • 8.2.2. Blood Bag Systems
    • 8.2.3. Leukocyte Reduction Filters
    • 8.2.4. Transfer Sets
    • 8.2.5. Tubing & Needles
  • 8.3. Equipment
    • 8.3.1. Collection Devices
      • 8.3.1.1. Apheresis Machines
      • 8.3.1.2. Blood Collection Mixers
    • 8.3.2. Irradiators
    • 8.3.3. Pathogen Reduction Systems
    • 8.3.4. Processing Equipment
      • 8.3.4.1. Automated Component Extractors
      • 8.3.4.2. Centrifuges
    • 8.3.5. Storage Equipment
      • 8.3.5.1. Blood Bank Refrigerators
      • 8.3.5.2. Cryogenic Freezers
      • 8.3.5.3. Plasma Freezers
      • 8.3.5.4. Platelet Incubators & Agitators
  • 8.4. Software
    • 8.4.1. Blood Establishment
    • 8.4.2. Temperature Monitoring

9. Blood Preparation Market, by Component

  • 9.1. Introduction
  • 9.2. Plasma
  • 9.3. Platelets
  • 9.4. Red Blood Cells
  • 9.5. Whole Blood

10. Blood Preparation Market, by Processing Automation

  • 10.1. Introduction
  • 10.2. Fully Automated
  • 10.3. Manual
  • 10.4. Semi-Automated

11. Blood Preparation Market, by Preparation Method

  • 11.1. Introduction
  • 11.2. Apheresis Processing
  • 11.3. Extraction Workflow
  • 11.4. Freezing & Cryopreservation
  • 11.5. Irradiation
  • 11.6. Leukoreduction
  • 11.7. Pathogen Inactivation
  • 11.8. Washing & Volume Adjustment
  • 11.9. Whole Blood Processing

12. Blood Preparation Market, by Application

  • 12.1. Introduction
  • 12.2. Plasma-Derived Therapies
    • 12.2.1. Autoimmune & Neurologic Disorders
    • 12.2.2. Liver Disease & Critical Care
    • 12.2.3. Primary Immunodeficiency
  • 12.3. Research & Biomanufacturing
  • 12.4. Transfusion Support
    • 12.4.1. Anemia Management
    • 12.4.2. Cardiovascular & Transplant
    • 12.4.3. Hematological Disorders
    • 12.4.4. Obstetrics & Gynecology
    • 12.4.5. Oncology Treatments

13. Blood Preparation Market, by End User

  • 13.1. Introduction
  • 13.2. Ambulatory Surgical Centers
  • 13.3. Blood Banks
  • 13.4. Clinics
  • 13.5. Hospitals

14. Americas Blood Preparation Market

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. Canada
  • 14.4. Mexico
  • 14.5. Brazil
  • 14.6. Argentina

15. Europe, Middle East & Africa Blood Preparation Market

  • 15.1. Introduction
  • 15.2. United Kingdom
  • 15.3. Germany
  • 15.4. France
  • 15.5. Russia
  • 15.6. Italy
  • 15.7. Spain
  • 15.8. United Arab Emirates
  • 15.9. Saudi Arabia
  • 15.10. South Africa
  • 15.11. Denmark
  • 15.12. Netherlands
  • 15.13. Qatar
  • 15.14. Finland
  • 15.15. Sweden
  • 15.16. Nigeria
  • 15.17. Egypt
  • 15.18. Turkey
  • 15.19. Israel
  • 15.20. Norway
  • 15.21. Poland
  • 15.22. Switzerland

16. Asia-Pacific Blood Preparation Market

  • 16.1. Introduction
  • 16.2. China
  • 16.3. India
  • 16.4. Japan
  • 16.5. Australia
  • 16.6. South Korea
  • 16.7. Indonesia
  • 16.8. Thailand
  • 16.9. Philippines
  • 16.10. Malaysia
  • 16.11. Singapore
  • 16.12. Vietnam
  • 16.13. Taiwan

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Fresenius Kabi AG
    • 17.3.2. Terumo Corporation
    • 17.3.3. Grifols, S.A.
    • 17.3.4. GVS S.p.A.
    • 17.3.5. Macopharma S.A.S.
    • 17.3.6. Baxter International Inc.
    • 17.3.7. CSL Limited
    • 17.3.8. B. Braun Melsungen AG
    • 17.3.9. Ortho Clinical Diagnostics Inc.
    • 17.3.10. Abbott Laboratories
    • 17.3.11. AdvaCare Pharma
    • 17.3.12. AstraZeneca PLC
    • 17.3.13. Bayer AG
    • 17.3.14. Becton, Dickinson, and Company
    • 17.3.15. Cardinal Health
    • 17.3.16. Daiichi Sankyo
    • 17.3.17. Exelint International, Co.
    • 17.3.18. GlaxoSmithKline PLC
    • 17.3.19. Greiner Bio-One International GmbH
    • 17.3.20. Medtronic PLC
    • 17.3.21. Pfizer Inc.
    • 17.3.22. QIAGEN N.V
    • 17.3.23. SARSTEDT AG & Co. KG
    • 17.3.24. Shanghai Kohope Medical Devices Co., Ltd.
    • 17.3.25. Immucor, Inc.
    • 17.3.26. Octapharma AG
    • 17.3.27. Kedrion Holding S.p.A.
    • 17.3.28. LFB SA
    • 17.3.29. Sanquin
    • 17.3.30. Medline Industries, Inc.
    • 17.3.31. Mitra Industries Private Limited
    • 17.3.32. Delcon SRL
    • 17.3.33. Labtron Equipment Ltd
    • 17.3.34. Nipro Corporation
    • 17.3.35. Labotronics Scientific LTD.

18. ResearchAI

19. ResearchStatistics

20. ResearchContacts

21. ResearchArticles

22. Appendix

LIST OF FIGURES

  • FIGURE 1. BLOOD PREPARATION MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL BLOOD PREPARATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL BLOOD PREPARATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL BLOOD PREPARATION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 16. GLOBAL BLOOD PREPARATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 18. AMERICAS BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 20. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 24. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 25. BLOOD PREPARATION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. BLOOD PREPARATION MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 27. BLOOD PREPARATION MARKET: RESEARCHAI
  • FIGURE 28. BLOOD PREPARATION MARKET: RESEARCHSTATISTICS
  • FIGURE 29. BLOOD PREPARATION MARKET: RESEARCHCONTACTS
  • FIGURE 30. BLOOD PREPARATION MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. BLOOD PREPARATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BLOOD PREPARATION MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD PREPARATION MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD PREPARATION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD PREPARATION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APHERESIS KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APHERESIS KITS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BAG SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BAG SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LEUKOCYTE REDUCTION FILTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LEUKOCYTE REDUCTION FILTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TRANSFER SETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TRANSFER SETS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TUBING & NEEDLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TUBING & NEEDLES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APHERESIS MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APHERESIS MACHINES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD COLLECTION MIXERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD COLLECTION MIXERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD PREPARATION MARKET SIZE, BY IRRADIATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD PREPARATION MARKET SIZE, BY IRRADIATORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AUTOMATED COMPONENT EXTRACTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AUTOMATED COMPONENT EXTRACTORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CENTRIFUGES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BANK REFRIGERATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BANK REFRIGERATORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CRYOGENIC FREEZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CRYOGENIC FREEZERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA FREEZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA FREEZERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLATELET INCUBATORS & AGITATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLATELET INCUBATORS & AGITATORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD ESTABLISHMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD ESTABLISHMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TEMPERATURE MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TEMPERATURE MONITORING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLATELETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLATELETS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL BLOOD PREPARATION MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BLOOD PREPARATION MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL BLOOD PREPARATION MARKET SIZE, BY MANUAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BLOOD PREPARATION MARKET SIZE, BY MANUAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SEMI-AUTOMATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SEMI-AUTOMATED, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APHERESIS PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APHERESIS PROCESSING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL BLOOD PREPARATION MARKET SIZE, BY EXTRACTION WORKFLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BLOOD PREPARATION MARKET SIZE, BY EXTRACTION WORKFLOW, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL BLOOD PREPARATION MARKET SIZE, BY FREEZING & CRYOPRESERVATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BLOOD PREPARATION MARKET SIZE, BY FREEZING & CRYOPRESERVATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 95. GLOBAL BLOOD PREPARATION MARKET SIZE, BY IRRADIATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BLOOD PREPARATION MARKET SIZE, BY IRRADIATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 97. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LEUKOREDUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LEUKOREDUCTION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 99. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PATHOGEN INACTIVATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PATHOGEN INACTIVATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 101. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WASHING & VOLUME ADJUSTMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WASHING & VOLUME ADJUSTMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 103. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WHOLE BLOOD PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WHOLE BLOOD PROCESSING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 105. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 107. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 109. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AUTOIMMUNE & NEUROLOGIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AUTOIMMUNE & NEUROLOGIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 111. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LIVER DISEASE & CRITICAL CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LIVER DISEASE & CRITICAL CARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 113. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PRIMARY IMMUNODEFICIENCY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PRIMARY IMMUNODEFICIENCY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 115. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2025-2030 (USD MILLION)
  • TABLE 117. GLOBAL BLOOD PREPARATION MARKET SIZE, BY RESEARCH & BIOMANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BLOOD PREPARATION MARKET SIZE, BY RESEARCH & BIOMANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 119. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 121. GLOBAL BLOOD PREPARATION MARKET SIZE, BY ANEMIA MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BLOOD PREPARATION MARKET SIZE, BY ANEMIA MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 123. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CARDIOVASCULAR & TRANSPLANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CARDIOVASCULAR & TRANSPLANT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 125. GLOBAL BLOOD PREPARATION MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BLOOD PREPARATION MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 127. GLOBAL BLOOD PREPARATION MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BLOOD PREPARATION MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 129. GLOBAL BLOOD PREPARATION MARKET SIZE, BY ONCOLOGY TREATMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BLOOD PREPARATION MARKET SIZE, BY ONCOLOGY TREATMENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 131. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2025-2030 (USD MILLION)
  • TABLE 133. GLOBAL BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BLOOD PREPARATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 135. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 137. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 139. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 141. GLOBAL BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 143. AMERICAS BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 145. AMERICAS BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 147. AMERICAS BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 149. AMERICAS BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2025-2030 (USD MILLION)
  • TABLE 151. AMERICAS BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 153. AMERICAS BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 155. AMERICAS BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 157. AMERICAS BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 159. AMERICAS BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2025-2030 (USD MILLION)
  • TABLE 161. AMERICAS BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 163. AMERICAS BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 165. AMERICAS BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2025-2030 (USD MILLION)
  • TABLE 167. AMERICAS BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2025-2030 (USD MILLION)
  • TABLE 169. AMERICAS BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS BLOOD PREPARATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 171. AMERICAS BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 173. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 174. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 175. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 176. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 177. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 178. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 179. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 180. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2025-2030 (USD MILLION)
  • TABLE 181. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 182. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 183. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 184. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 185. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 186. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 187. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 188. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 189. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2024 (USD MILLION)
  • TABLE 190. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2025-2030 (USD MILLION)
  • TABLE 191. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 192. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 193. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 195. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2024 (USD MILLION)
  • TABLE 196. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2025-2030 (USD MILLION)
  • TABLE 197. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 198. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2025-2030 (USD MILLION)
  • TABLE 199. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 201. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 202. UNITED STATES BLOOD PREPARATION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 203. CANADA BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 204. CANADA BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 205. CANADA BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 206. CANADA BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 207. CANADA BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 208. CANADA BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 209. CANADA BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 210. CANADA BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2025-2030 (USD MILLION)
  • TABLE 211. CANADA BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 212. CANADA BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 213. CANADA BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 214. CANADA BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 215. CANADA BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 216. CANADA BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 217. CANADA BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 218. CANADA BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 219. CANADA BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2024 (USD MILLION)
  • TABLE 220. CANADA BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2025-2030 (USD MILLION)
  • TABLE 221. CANADA BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 222. CANADA BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 223. CANADA BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. CANADA BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 225. CANADA BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2024 (USD MILLION)
  • TABLE 226. CANADA BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2025-2030 (USD MILLION)
  • TABLE 227. CANADA BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 228. CANADA BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2025-2030 (USD MILLION)
  • TABLE 229. CANADA BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. CANADA BLOOD PREPARATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 231. MEXICO BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 232. MEXICO BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 233. MEXICO BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 234. MEXICO BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 235. MEXICO BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 236. MEXICO BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 237. MEXICO BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 238. MEXICO BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2025-2030 (USD MILLION)
  • TABLE 239. MEXICO BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 240. MEXICO BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 241. MEXICO BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 242. MEXICO BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 243. MEXICO BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 244. MEXICO BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 245. MEXICO BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 246. MEXICO BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 247. MEXICO BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2024 (USD MILLION)
  • TABLE 248. MEXICO BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2025-2030 (USD MILLION)
  • TABLE 249. MEXICO BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 250. MEXICO BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 251. MEXICO BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. MEXICO BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 253. MEXICO BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2024 (USD MILLION)
  • TABLE 254. MEXICO BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2025-2030 (USD MILLION)
  • TABLE 255. MEXICO BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 256. MEXICO BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2025-2030 (USD MILLION)
  • TABLE 257. MEXICO BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 258. MEXICO BLOOD PREPARATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 259. BRAZIL BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 260. BRAZIL BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 261. BRAZIL BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 262. BRAZIL BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 263. BRAZIL BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 264. BRAZIL BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 265. BRAZIL BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 266. BRAZIL BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2025-2030 (USD MILLION)
  • TABLE 267. BRAZIL BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 268. BRAZIL BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 269. BRAZIL BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 270. BRAZIL BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 271. BRAZIL BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 272. BRAZIL BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 273. BRAZIL BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 274. BRAZIL BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 275. BRAZIL BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2024 (USD MILLION)
  • TABLE 276. BRAZIL BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2025-2030 (USD MILLION)
  • TABLE 277. BRAZIL BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 278. BRAZIL BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 279. BRAZIL BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 280. BRAZIL BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 281. BRAZIL BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2024 (USD MILLION)
  • TABLE 282. BRAZIL BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2025-2030 (USD MILLION)
  • TABLE 283. BRAZIL BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 284. BRAZIL BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2025-2030 (USD MILLION)
  • TABLE 285. BRAZIL BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. BRAZIL BLOOD PREPARATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 287. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 288. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 289. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 290. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 291. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 292. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 293. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 294. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2025-2030 (USD MILLION)
  • TABLE 295. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 296. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 297. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 298. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 299. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 300. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 301. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 302. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 303. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2024 (USD MILLION)
  • TABLE 304. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2025-2030 (USD MILLION)
  • TABLE 305. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 306. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 307. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 308. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 309. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2024 (USD MILLION)
  • TABLE 310. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2025-2030 (USD MILLION)
  • TABLE 311. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 312. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2025-2030 (USD MILLION)
  • TABLE 313. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 314. ARGENTINA BLOOD PREPARATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 315. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 317. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 319. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 321. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2025-2030 (USD MILLION)
  • TABLE 323. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 324. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 325. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 326. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 327. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 328. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 329. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 330. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 331. EUROPE, MIDDLE EAST